RxDoctor Payments Data

John Caras

Endocrinology, Diabetes & Metabolism · Wichita Falls, TXNPI 1639157837

Payments from drug & device makers

$5,430in general payments, 2019–2025

Across 131 payments — averaging $41.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$3K
  • Novo Nordisk$1K
  • Sanofi-aventis U.S. LLC$396
  • Medtronic$217
  • Abbott$142
  • IBSA Pharma Inc.$66
  • plus $302 from 13 others

What the payments were for

  • Consulting fees$2,25041%
  • Travel & lodging$4448%
  • Food & beverage$2,73650%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,430 in reported general payments places this provider in the 50th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

See all endocrinology, diabetes & metabolism providers in Texas

Other endocrinology, diabetes & metabolism in Wichita Falls

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →